SIMG
LAB icon

Stephens Investment Management Group’s Standard BioTools LAB Stock Holding History

Stephens Investment Management Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-258,681
Closed -$6.26M – 189
2015
Q2 		$6.26M Sell
258,681
-990
-0.4% -$31.2K 0.18% 141
2015
Q1 		$10.9M Sell
259,671
-42,124
-14% -$1.67M 0.33% 119
2014
Q4 		$10.2M Buy
301,795
+28,705
+11% +$813K 0.3% 123
2014
Q3 		$6.69M Buy
273,090
+43,715
+19% +$1.23M 0.2% 142
2014
Q2 		$6.74M Buy
229,375
+28,120
+14% +$901K 0.21% 146
2014
Q1 		$8.87M Buy
+201,255
New +$8.85M 0.27% 127

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stephens Investment Management Group's LAB Position: Q3 2015 in Review

Stephens Investment Management Group sold out of Standard BioTools (LAB) in Q3 2015, closing a stake of 258,681 shares — an estimated $6.26M sold.

Stephens Investment Management Group first reported a position in LAB in Q1 2014 and held it in 6 quarters. The position peaked at $10.9M in Q1 2015. 109 funds tracked by Wall St. Rank hold LAB as of Q3 2015.

  • Stephens Investment Management Group reported no remaining Standard BioTools position as of Q3 2015 after selling out during the quarter.
  • Stephens Investment Management Group sold 258,681 Standard BioTools shares in Q3 2015, an estimated $6.26M.
  • Stephens Investment Management Group first reported a position in Standard BioTools in Q1 2014 and held it in 6 quarters.
  • Stephens Investment Management Group's Standard BioTools position peaked at $10.9M in Q1 2015.
  • 109 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2015.

Based on Stephens Investment Management Group's 13F filing for Q3 2015, filed 3 Nov 2015.